Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Jamie Findlow, Paul Balmer & Ray Borrow. (2019) A review of complement sources used in serum bactericidal assays for evaluating immune responses to meningococcal ACWY conjugate vaccines. Human Vaccines & Immunotherapeutics 15:10, pages 2491-2500.
Read now
Read now
Justine Alderfer, Amit Srivastava, Raul Isturiz, Cynthia Burman, Judith Absalon, Johannes Beeslaar & John Perez. (2019) Concomitant administration of meningococcal vaccines with other vaccines in adolescents and adults: a review of available evidence. Human Vaccines & Immunotherapeutics 15:9, pages 2205-2216.
Read now
Read now
Beatriz P. Quiambao, Hermant Jain, Ashish Bavdekar, Anand Prakash Dubey, Devayani Kolhe, Véronique Bianco, Marie Van der Wielen & Jacqueline M. Miller. (2016) Persistence of the immune response two years after vaccination with quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in Asian adolescents. Human Vaccines & Immunotherapeutics 12:8, pages 2162-2168.
Read now
Read now
Aia Assaf-Casals & Ghassan Dbaibo. (2016) Meningococcal quadrivalent tetanus toxoid conjugate vaccine (MenACWY-TT, Nimenrix™): A review of its immunogenicity, safety, co-administration, and antibody persistence. Human Vaccines & Immunotherapeutics 12:7, pages 1825-1837.
Read now
Read now
Yorgo C Zahlanie, Moza M Hammadi, Soha T Ghanem & Ghassan S Dbaibo. (2014) Review of meningococcal vaccines with updates on immunization in adults. Human Vaccines & Immunotherapeutics 10:4, pages 995-1007.
Read now
Read now
Carine P Hedari, Rima W Khinkarly & Ghassan S Dbaibo. (2014) Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease. Infection and Drug Resistance 7, pages 85-99.
Read now
Read now
Soha Ghanem, Sara Hassan, Randa Saad & Ghassan S Dbaibo. (2013) Quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine (MenACWY-TT): a review. Expert Opinion on Biological Therapy 13:8, pages 1197-1205.
Read now
Read now
Articles from other publishers (11)
Redouane Abouqal, Maher Beji, Mohamed Chakroun, Kamal Marhoum El Filali, Jihane Rammaoui & Hela Zaghden. (2022) Trends in Adult and Elderly Vaccination: Focus on Vaccination Practices in Tunisia and Morocco. Frontiers in Public Health 10.
Crossref
Crossref
Si Si, Ella Zomer, Samantha Fletcher, Jenny Lee & Danny Liew. (2019) Cost-effectiveness of meningococcal polysaccharide serogroups A, C, W-135 and Y conjugate vaccine in Australian adolescents. Vaccine 37:35, pages 5009-5015.
Crossref
Crossref
Jamie Findlow & Markus Knuf. (2019) Immunogenicity and safety of meningococcal group A, C, W and Y tetanus toxoid conjugate vaccine: review of clinical and real-world evidence. Future Microbiology 14:7, pages 563-580.
Crossref
Crossref
Sohita Dhillon & David Pace. (2017) Meningococcal Quadrivalent Tetanus Toxoid Conjugate Vaccine (MenACWY-TT; Nimenrix®): A Review. Drugs 77:17, pages 1881-1896.
Crossref
Crossref
Roberto Gasparini, Miguel Tregnaghi, Pavitra Keshavan, Ellen Ypma, Linda Han & Igor Smolenov. (2016) Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine and Commonly Administered Vaccines After Coadministration. Pediatric Infectious Disease Journal 35:1, pages 81-93.
Crossref
Crossref
Paolo Pellegrino, Valentina Perrone, Sonia Radice, Annalisa Capuano & Emilio Clementi. (2015) Immunogenicity of meningococcal quadrivalent (serogroup A, C, W135 and Y) tetanus toxoid conjugate vaccine: Systematic review and meta-analysis. Pharmacological Research 92, pages 31-39.
Crossref
Crossref
Nicola P. Klein, Yaela Baine, Veronique Bianco, Pascal R. Lestrate, Aftab Naz, Mark Blatter, Leonard R. Friedland & Jacqueline M. Miller. (2013) One or Two Doses of Quadrivalent Meningococcal Serogroups A, C, W-135 and Y Tetanus Toxoid Conjugate Vaccine Is Immunogenic in 9- to 12-Month-Old Children. Pediatric Infectious Disease Journal 32:7, pages 760-767.
Crossref
Crossref
Ghassan Dbaibo, Nabil El-Ayoubi, Soha Ghanem, Farah Hajar, Veronique Bianco, Jacqueline M. Miller & Narcisa Mesaros. (2013) Immunogenicity and Safety of a Quadrivalent Meningococcal Serogroups A, C, W-135 and Y Tetanus Toxoid Conjugate Vaccine (MenACWY-TT) Administered to Adults Aged 56 Years and Older: Results of an Open-Label, Randomized, Controlled Trial. Drugs & Aging 30:5, pages 309-319.
Crossref
Crossref
Helen Findlow & Ray Borrow. (2013) Immunogenicity and Safety of a Meningococcal Serogroup A, C, Y and W Glycoconjugate Vaccine, ACWY-TT. Advances in Therapy 30:5, pages 431-458.
Crossref
Crossref
Jamie D. Croxtall & Sohita Dhillon. (2012) Meningococcal Quadrivalent (Serogroups A, C, W135 and Y) Tetanus Toxoid Conjugate Vaccine (Nimenrix™). Drugs 72:18, pages 2407-2430.
Crossref
Crossref
Paul B Keiser & Christopher J Gill. (2012) Defining efficacy in meningococcal vaccine trials. Clinical Investigation 2:6, pages 589-601.
Crossref
Crossref